149 related articles for article (PubMed ID: 11575530)
1. Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing.
Gätke MR; Ostergaard D; Bundgaard JR; Varin F; Viby-Mogensen J
Anesthesiology; 2001 Sep; 95(3):600-6. PubMed ID: 11575530
[TBL] [Abstract][Full Text] [Related]
2. Response to mivacurium in patients carrying the k variant in the butyrylcholinesterase gene.
Gätke MR; Viby-Mogensen J; Ostergaard D; Bundgaard JR
Anesthesiology; 2005 Mar; 102(3):503-8. PubMed ID: 15731585
[TBL] [Abstract][Full Text] [Related]
3. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).
Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Pedersen NA; Skovgaard LT
Acta Anaesthesiol Scand; 2003 Nov; 47(10):1219-25. PubMed ID: 14616318
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
Delacour H; Lushchekina S; Mabboux I; Ceppa F; Masson P; Schopfer LM; Lockridge O
Biochem Pharmacol; 2014 Dec; 92(3):476-83. PubMed ID: 25264279
[TBL] [Abstract][Full Text] [Related]
6. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene.
Wichmann S; Færk G; Bundgaard JR; Gätke MR
Pharmacogenet Genomics; 2016 Jul; 26(7):351-6. PubMed ID: 27031121
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
Lien CA; Schmith VD; Embree PB; Belmont MR; Wargin WA; Savarese JJ
Anesthesiology; 1994 Jun; 80(6):1296-302. PubMed ID: 8010476
[TBL] [Abstract][Full Text] [Related]
8. The pharmacodynamics and pharmacokinetics of mivacurium in children.
ØStergaard D; Gätke MR; Berg H; Rasmussen SN; Viby-Mogensen J
Acta Anaesthesiol Scand; 2002 May; 46(5):512-8. PubMed ID: 12027844
[TBL] [Abstract][Full Text] [Related]
9. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium.
Ostergaard D; Rasmussen SN; Viby-Mogensen J; Pedersen NA; Boysen R
Anesthesiology; 2000 Jun; 92(6):1581-7. PubMed ID: 10839906
[TBL] [Abstract][Full Text] [Related]
10. Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.
Cerf C; Mesguish M; Gabriel I; Amselem S; Duvaldestin P
Anesth Analg; 2002 Feb; 94(2):461-6, table of contents. PubMed ID: 11812719
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase.
Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Varin F
Anesthesiology; 2005 Jun; 102(6):1124-32. PubMed ID: 15915024
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of mivacurium in young adult and elderly patients.
ØStergaard D; Viby-Mogensen J; Pedersen NA; Holm H; Skovgaard LT
Acta Anaesthesiol Scand; 2002 Jul; 46(6):684-91. PubMed ID: 12059892
[TBL] [Abstract][Full Text] [Related]
13. Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing.
Rosenberg MK; Lebenbom-Mansour M
Anesth Analg; 1997 Feb; 84(2):457-60. PubMed ID: 9024049
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics of mivacurium isomers and their metabolites in healthy volunteers after intravenous bolus administration.
Lacroix M; Donati F; Varin F
Anesthesiology; 1997 Feb; 86(2):322-30. PubMed ID: 9054251
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of mivacurium stereoisomers in beagle dogs using twitch height and train-of-four response.
Lugo SI; Liang Z; Eddington ND
Biopharm Drug Dispos; 1998 Nov; 19(8):485-91. PubMed ID: 9840210
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and steady state pharmacodynamics of mivacurium in children.
Markakis DA; Lau M; Brown R; Luks AM; Sharma ML; Fisher DM
Anesthesiology; 1998 Apr; 88(4):978-83. PubMed ID: 9579507
[TBL] [Abstract][Full Text] [Related]
17. [Value of the monitoring of curarisation during prolonged mivacurium induced neuromuscular block].
Avargues P; Cros AM; Dardel E; Darriet M; Biteau N
Ann Fr Anesth Reanim; 1995; 14(6):511-3. PubMed ID: 8745977
[TBL] [Abstract][Full Text] [Related]
18. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Eskildsen KZ; Gätke MR
Ugeskr Laeger; 2015 Apr; 177(18):866-8. PubMed ID: 26539575
[TBL] [Abstract][Full Text] [Related]
19. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Eskildsen KZ; Gätke MR
Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350885
[TBL] [Abstract][Full Text] [Related]
20. Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity.
Ostergaard D; Jensen FS; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1995 Nov; 39(8):1016-8. PubMed ID: 8607300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
